Pharmaceutical Executive March 14, 2024
Cosgrove discusses how a recent study utilized a high-tech data platform to bring a new perspective on data to the researchers.
Dr. David Cosgrove, a medical oncologist with Compass Oncology, presented the results of a study on the first-line use of atezolizumab plus bevacizumab on patients with a certain type of liver cancer at ASCO GI earlier this year. He recently spoke with Pharmaceutical Executive about some of the methods used in the study to bring real-world data into the fold.
Pharmaceutical Executive: How did this study utilize Ontada’s iKnowMed EHR System?
David Cosgrove: Our network across the country utilizes a unified EHR, which is called iKnowMed (IKM). That houses both our clinical documentation and results information. It also has a...
Today's Sponsors
Today's Sponsor